PCR Technologies Market

The PCR technologies market is projected to reach USD 21.89 Billion by 2030 from USD 14.61 Billion in 2024, growing at a CAGR of 7.0 % during the forecast period. A number of significant reasons are supporting the growth of the PCR technologies market. Demand for this market is enhanced by factors such as increase in  cases of  genetic disorders and infectious & chronic diseases , consistent innovations in PCR methods, government led initiatives  and increase in expenditure on R&D. However, high cost of equipment such as of dPCR and qPCR and the technical complexities of PCR-based devices are the factors that can limit the growth of this market.

Prominent players in the PCR technologies market include F. Hoffman-La Roche Ltd. (Switzerland), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Germany), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), Standard Biotools (US),Lonza (Switzerland),  Danaher Corporation (US), Abbott Laboratories (US), Merck KGaA (Germany), Bioneer Corporation (South Korea), PerkinElmer Inc. (US), Hologic Inc. (US), Sansure Biotech Inc. (China) Becton, Dickinson and Company (US) and Analytik Jena AG (Germany).

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific Inc. (US):  Thermo Fisher Scientific is a prominent player that offers wide range of products across the world. The product portfolio of this firm comprise PCR instruments, reagents & consumables and software for traditional PCR as well as advanced qPCR (quantitative PCR). The company has global presence in more than 50 countries. The firm actively engages in numerous growth strategies such as product launches, partnerships, acquiistions  collaborations and expansions. For instance, in November 2023, the firm launched RT-PCR Flu A/Flu B test to identify and differentiate between influenza A and B in  approximate 30 minutes.

F. Hoffmoann La-Roche Ltd. (Switzerland): Roche Diagnostics is leading in biotechnology and diagnostics and is a well-established player in PCR (Polymerase Chain Reaction) market. The product portfolio of this firm includes PCR instruments, software and reagents & consumables. The company also participates in inorganic growth strategies that comprise partnership, collaboration and acquisitions. For instance, in September 2021, the company acquired TIB Molbiol (Germany) to include new infectious diseases in its PCR product portfolio.  The company concentrates on product integration by launching products that are compatible with the users and assist it to mark its presence in the PCR market.

Bio-Rad Laboratories, Inc. (US): Bio-Rad Laboratories is a key players in clinical diagnostics and life science. The company holds a global presence in PCR market in over 100 countries across Americas, Asia, Europe, and the Middle East. The firm is associated with the manufacturing, and selling of over  5,000 reagents and laboratory equipment (including qPCR and dPCR products). To mark its presence in PCR market, the company engages in strategic collaborations and acquisitions. For instance, in August 2022, the firm acquired Curiosity Diagnostics (Poland) which is aimed to manufacture quick diagnostics PCR system.

Related Reports:

PCR Technologies Market by Product (Instruments, Reagents & Consumables, Software), Application (Genotyping, Diagnostic Applications), Technique (Reverse Transcription PCR, qPCR), Enduser (Hospital Labs, Diagnostic Labs) - Global Forecasts to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]